Core Viewpoint - The announcement reveals that major shareholders of MediTech plan to reduce their holdings, indicating potential changes in ownership structure and market sentiment [1] Shareholder Reduction Plans - Shareholder Weng Kang intends to reduce his holdings by up to 5.2142 million shares, which represents no more than 1.7% of the company's total share capital [1] - The reduction will be executed through block trades and centralized bidding, with a maximum of 5.2142 million shares and 3.0628 million shares respectively [1] - Another shareholder, Wu Di, plans to reduce his holdings by up to 14,300 shares, accounting for no more than 0.0047% of the company's total share capital [1] - The implementation of these reduction plans is subject to market conditions and personal financial arrangements, indicating uncertainty [1]
麦迪科技:股东翁康拟减持股份不超1.7%